Synchronous bilateral breast cancer in an aged male patient.
BACKGROUND
Male breast cancer is an uncommon disease. Moreover, synchronous bilateral breast cancer is extremely rare in men. The management is still undefined, although it shows similarities to breast cancers in women.


METHODS
We report the case of a 66-year-old male patient who presented with palpable bilateral breast masses. Synchronous bilateral breast cancer was diagnosed with imaging studies and tru-cut biopsy. Histopathological examination revealed bilateral early-stage breast cancer. None of the possible predisposing factors, including hormonal and hereditary history, could be detected. Following bilateral modified radical mastectomy, the patient received adjuvant chemotherapy with tamoxifen. The pertinent literature is reviewed.


CONCLUSIONS
More studies are warranted to better identify possible risk factors for male breast cancers.
Yaman
Emel
E
Department of Medical Oncology, Mersin State Hospital, Mersin, Turkey. emel.yaman@gmail.com
Ozturk
Banu
B
Coskun
Ugur
U
Buyukberber
Suleyman
S
Kaya
Ali Osman
AO
Yildiz
Ramazan
R
Benekli
Mustafa
M
D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001706:Biopsy; D001940:Breast / Q000473:pathology; D018567:Breast Neoplasms, Male / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D015411:Mastectomy, Modified Radical; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D013629:Tamoxifen / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen